Phase II study of XR 5000, an inhibitor of topoisomerases I and II, in advanced colorectal cancer
| Autor: | Caponigro, F, Dittrich, C, Sorensen, J.B, Schellens, J.H.M, Duffaud, F, Paz Ares, L, Lacombe, D, de Balincourt, C, Fumoleau, P |
|---|---|
| Zdroj: | In European Journal of Cancer January 2002 38(1):70-74 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect